Lista de obras -

2492. Clinical, Virologic, and Immunologic Characteristics of Zika Virus Infection in a Cohort of US Patients

scholarly article by Hana M El Sahly et al published November 2018 in Open Forum Infectious Diseases

A randomized, double-blind, controlled trial of the 17D yellow fever virus vaccine given in combination with immune globulin or placebo: comparative viremia and immunogenicity

artículo científico publicado en 2012

Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials

artículo científico publicado en 2017

Biphasic Zika Illness With Rash and Joint Pain

artículo científico

Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection

artículo científico publicado en 2011

Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection

artículo científico publicado en 2011

Clinical, Virologic, and Immunologic Characteristics of Zika Virus Infection in a Cohort of US Patients: Prolonged RNA Detection in Whole Blood

article

Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects

artículo científico publicado en 2015

Cytotoxic T-lymphocyte responses to canarypox vector-based HIV vaccines in HIV-seronegative individuals: a meta-analysis of published studies

artículo científico publicado en 2004

DNA priming for seasonal influenza vaccine: a phase 1b double-blind randomized clinical trial

artículo científico publicado en 2015

Detection of anti-yellow fever virus immunoglobulin m antibodies at 3-4 years following yellow fever vaccination

artículo científico publicado en 2012

Enrollment in YFV Vaccine Trial: An Evaluation of Recruitment Outcomes Associated with a Randomized Controlled Double-Blind Trial of a Live Attenuated Yellow Fever Vaccine.

artículo científico publicado en 2013

First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090).

artículo científico publicado en 2015

Fusarium falciforme vertebral abscess and osteomyelitis: case report and molecular classification

artículo científico publicado en 2011

Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus

artículo científico publicado en 2016

Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines

artículo científico publicado en 2008

Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons

artículo científico publicado en 2012

Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial

artículo científico

Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans.

artículo científico publicado en 2014

Initial viral load determines the magnitude of the human CD8 T cell response to yellow fever vaccination

artículo científico publicado en 2015

Innate, T and B Cell Responses in Acute Human Zika Patients

artículo científico publicado en 2017

Origin and differentiation of human memory CD8 T cells after vaccination

artículo científico publicado en 2017

Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells

artículo científico publicado en 2012

Pericarditis Associated With Acute Zika Virus Infection in a Returning Traveler

artículo científico publicado en 2017

Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations

artículo científico publicado en 2014

Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial

artículo científico publicado en 2014

Rapid generation of neutralizing antibody responses in COVID-19 patients

artículo científico publicado en 2020

Recognition of influenza H3N2 variant virus by human neutralizing antibodies

scientific article published on July 2016

Rethinking typhoid fever vaccines: implications for travelers and people living in highly endemic areas

artículo científico publicado en 2009

Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years Old

artículo científico publicado en 2015

Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery

artículo científico publicado en 2013

Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adults

artículo científico publicado en 2009

Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant

artículo científico publicado en 2011

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

artículo científico publicado en 2017

Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial

artículo científico

Strategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1

artículo científico publicado en 2012

Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans

artículo científico publicado en 2020

The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients

scientific article published on 01 June 2020

The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response

artículo científico publicado en 2009

Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial

artículo científico publicado en 2017

Lista de obras de

2492. Clinical, Virologic, and Immunologic Characteristics of Zika Virus Infection in a Cohort of US Patients

A randomized, double-blind, controlled trial of the 17D yellow fever virus vaccine given in combination with immune globulin or placebo: comparative viremia and immunogenicity

Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials

Biphasic Zika Illness With Rash and Joint Pain

Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection

Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection

Clinical, Virologic, and Immunologic Characteristics of Zika Virus Infection in a Cohort of US Patients: Prolonged RNA Detection in Whole Blood

Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects

Cytotoxic T-lymphocyte responses to canarypox vector-based HIV vaccines in HIV-seronegative individuals: a meta-analysis of published studies

DNA priming for seasonal influenza vaccine: a phase 1b double-blind randomized clinical trial

Detection of anti-yellow fever virus immunoglobulin m antibodies at 3-4 years following yellow fever vaccination

Enrollment in YFV Vaccine Trial: An Evaluation of Recruitment Outcomes Associated with a Randomized Controlled Double-Blind Trial of a Live Attenuated Yellow Fever Vaccine.

First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090).

Fusarium falciforme vertebral abscess and osteomyelitis: case report and molecular classification

Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus

Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines

Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons

Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial

Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans.

Initial viral load determines the magnitude of the human CD8 T cell response to yellow fever vaccination

Innate, T and B Cell Responses in Acute Human Zika Patients

Origin and differentiation of human memory CD8 T cells after vaccination

Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells

Pericarditis Associated With Acute Zika Virus Infection in a Returning Traveler

Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations

Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial

Rapid generation of neutralizing antibody responses in COVID-19 patients

Recognition of influenza H3N2 variant virus by human neutralizing antibodies

Rethinking typhoid fever vaccines: implications for travelers and people living in highly endemic areas

Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years Old

Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery

Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adults

Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial

Strategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1

Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans

The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients

The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response

Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial